Where Hologic Stands With Analysts
Portfolio Pulse from Benzinga Insights
Hologic (NASDAQ:HOLX) has received mixed analyst ratings in the last quarter, with 1 bullish, 1 somewhat bullish, and 3 indifferent ratings. The average 12-month price target from 5 analysts is $79.8, which is a 7.42% decrease from the previous target of $86.20. Analysts provide ratings based on financial analysis and company insights, and these ratings are updated typically once a quarter.
November 13, 2023 | 8:00 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Hologic has a mixed outlook from analysts, with an average price target suggesting a slight decrease in stock value. The current average price target is $79.8, down from $86.20.
The decrease in the average price target for Hologic suggests that analysts expect the stock to perform worse in the future compared to previous expectations. This could lead to a negative short-term impact on the stock price as investors adjust their expectations.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100